Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concerns.
about
Mitochondrial dysfunction and mitophagy activation in blood mononuclear cells of fibromyalgia patients: implications in the pathogenesis of the diseaseFibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatmentMetabolomics analysis and modeling suggest a lysophosphocholines-PAF receptor interaction in fibromyalgiaClinical symptoms in fibromyalgia are better associated to lipid peroxidation levels in blood mononuclear cells rather than in plasma.Antioxidant supplementation reduces endometriosis-related pelvic pain in humansEvidence of oxidative stress in temporomandibular disorders: a pilot study.Women with fibromyalgia have lower levels of calcium, magnesium, iron and manganese in hair mineral analysis.Oxidative stress in fibromyalgia and its relationship to symptomsNLRP3 inflammasome is activated in fibromyalgia: the effect of coenzyme Q10.Deciphering the mechanism(s) of action of natural products: analgesic peroxide oil as example.Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications.The role of mitochondrial dysfunctions due to oxidative and nitrosative stress in the chronic pain or chronic fatigue syndromes and fibromyalgia patients: peripheral and central mechanisms as therapeutic targets?Fibromyalgia syndrome and temporomandibular disorders with muscular pain. A review.Comparison of Serum and Salivary Antioxidants in Patients with Temporomandibular Joint Disorders and Healthy Subjects.Ambroxol for the treatment of fibromyalgia: science or fiction?Vitamins C and E treatment combined with exercise modulates oxidative stress markers in blood of patients with fibromyalgia: a controlled clinical pilot study.Association of serum total antioxidant capacity and total oxidant status with pain perception in patients with myofacial pain dysfunction.Serum levels of high mobility group box 1 protein and its association with quality of life and psychological and functional status in patients with fibromyalgia.Involvement of TRPM2 and TRPV1 channels on hyperalgesia, apoptosis and oxidative stress in rat fibromyalgia model: Protective role of selenium.Effects of 12-week combined exercise therapy on oxidative stress in female fibromyalgia patients.Some oxidative and antioxidative parameters and their relationship with clinical symptoms in women with fibromyalgia syndrome.
P2860
Q21195362-F71ADA34-DB9E-4871-8E3A-2A91F7C59BDFQ21296574-4AD164CC-1D98-44C3-9263-FD52135125D2Q27346943-C7208D19-F094-4532-956D-3D16F54ECF24Q34064822-17CDE4F9-6D01-4E71-BAA0-68F6D490683FQ34283752-AB8F6B34-D5C7-420A-8901-32A39431ECF3Q35156853-EE8B21D6-6162-40CE-808C-32A2DDF242F9Q35333527-6C0EF32E-5F38-48AE-A93C-6FCF0BEECFB3Q37124549-9F49E12E-D9C4-4DE2-BA20-680347CC38A6Q37602813-DAF4FA7C-4320-4D40-8F17-3C2F72EF50C8Q37872360-8E911D8B-E946-4E49-A021-1097C9E6F971Q38114007-A19627E3-2196-4179-A6EC-902FF50EEA66Q38120080-07E82F04-A50B-4FBD-8FA1-35B638AA3143Q38931472-E4FCE59A-48BE-4542-AE29-32C61F4EA385Q40258011-24515753-03DA-4E5A-A227-E56165D601FCQ41483222-C057F6A4-5BBB-48DC-95C1-BCE0F713D633Q42953755-6ED1EFDD-D6B6-4264-A516-CDE92A593A70Q43239590-088210BE-EE89-4DB3-B307-EF199C1F6B99Q43530242-CEEF01EB-C28A-4BCE-B3E7-D9AE3EC370A8Q46242302-19488984-BBBB-4B2C-965B-0369B8B2FC17Q48338683-EBF983C2-97E8-4D26-BE94-F4E2C7BC113AQ51005390-B59EA53B-D7E5-4EBB-898D-AD6A9D417E4A
P2860
Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concerns.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Antioxidant status, lipid pero ...... ogic and therapeutic concerns.
@en
Antioxidant status, lipid pero ...... ogic and therapeutic concerns.
@nl
type
label
Antioxidant status, lipid pero ...... ogic and therapeutic concerns.
@en
Antioxidant status, lipid pero ...... ogic and therapeutic concerns.
@nl
prefLabel
Antioxidant status, lipid pero ...... ogic and therapeutic concerns.
@en
Antioxidant status, lipid pero ...... ogic and therapeutic concerns.
@nl
P2093
P1476
Antioxidant status, lipid pero ...... ogic and therapeutic concerns.
@en
P2093
Hulya Yildizhan
Huseyin Ozyurt
Omer Akyol
Ozge Ardicoglu
Sadik Sogut
P2888
P304
P356
10.1007/S00296-005-0079-Y
P577
2005-11-10T00:00:00Z